Selective anaplastic lymphoma kinase (ALK) degrader (DC50 values are 10 and 40 nM in H3122 and Karpas 299 cells, respectively). Comprises the cereblon E3 ligase ligand Pomalidomide (Cat. No. 6302) conjugated to an ALK inhibitor. Inhibits proliferation of ALK-positive cancer cell lines. Maximum degradation exhibited at 16 h.
Negative control TL 13-110 (Cat. No. 6746) also available.
TL 13-112 is a selective anaplastic lymphoma kinase (ALK) Degrader (PROTAC®) (DC50 values are 10 and 40 nM in H3122 and Karpas 299 cells, respectively). Comprises the cereblon E3 ligase ligand Pomalidomide (Cat. No. 6302) conjugated to an ALK inhibitor. Inhibits proliferation of ALK-positive cancer cell lines. Maximum degradation exhibited at 16 h.
Negative control TL 13-110 (Cat. No. 6746) also available.
Caractéristiques techniques
| Marque | Tocris Bioscience |
|---|
| Réf. B-LABO | BL-RE-125117 |
|---|
| Réf. fabricant | 18755546 |
|---|
| Nom chimique ou matériau | N-[2-[2-[2-[4-[4-[[5-Chloro-4-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-2-pyrimidinyl]amino]-2-methyl-5-(1-methylethoxy)phenyl]-1-piperidinyl]ethoxy]ethoxy]ethyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]acetamide |
|---|
| CAS | 2229037-19-6 |
|---|
| Quantité | 5 mg |
|---|
| Formule moléculaire | C<sub>49</sub>H<sub>60</sub>ClN<sub>9</sub>O<sub>10</sub>S |
|---|
| Poids de la formule | 1002.57 |
|---|
| Pureté | 98% |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
